跳至主要内容
临床试验/NCT04007133
NCT04007133终止不适用

Evaluation of Statin Compliance of Patients With Non-insulin-dependent Diabetes

Lille Catholic University1 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2018年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
119
试验地点
1
主要终点
Compliance rate with statin measured by the Girerd test

研究概览

简要总结

The diabetic population has an increased cardiovascular risk compared to the general population.

Hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase) inhibitors, or "statins", are considered as the standard treatment for hypercholesterolemia.

Many patients with non-insulin-dependent diabetes are prescribed with statins, both for primary prevention, before the first cardiovascular event, and as secondary prevention, to avoid recurrence.

However, compliance to these drugs may be difficult due to polypharmacy, side effects (myalgia) or tiredness.

The purpose of this study is to determine the compliance of diabetic patients with statins searching for important factors which could favor adherence.

详细描述

The diabetic population has an increased cardiovascular risk compared to the general population. The mortality of people with diabetes due to ischemic heart disease is multiplied by 2.2, and when is due to cerebrovascular disease by 1.8 compared to those patients without diabetes. Hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase) inhibitors, or "statins", are considered as the standard treatment for hypercholesterolemia.

Statins have been shown to be effective in reducing the risk of cardiovascular events, each 1 mmol decrease in LDL cholesterol reduces the risk of cardiovascular events by 21% at 5 years.

Many patients with non-insulin-dependent diabetes are prescribed with statins, both for primary prevention, before the first cardiovascular event, and for secondary prevention, to avoid recurrence.

However, compliance with these drugs may be difficult due to polypharmacy, side effects (myalgia) or tiredness. Indeed, the persistence of statin use, one year after its prescription, is estimated at 70% in the general population. However, there are no data in the French population, and in particular on French diabetic patients for whom the cardiovascular risk is increased compared to the general population.

The purpose of this study is to determine the compliance of diabetic patients with statins searching for important factors which could favor adherence.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major patients
  • With non-insulin-dependent diabetes, taking statins for at least 1 month (to assess compliance)
  • Hospitalized in the Diabetology Day Hospital of the Saint Philibert Hospital
  • In capacity to answer the Girerd test
  • Patient who has been informed and not opposed to the study

排除标准

  • Patient's refusal to participate in the study
  • Patient under guardianship or curatorship

结局指标

主要结局

Compliance rate with statin measured by the Girerd test

时间窗: Day 0

This is a simple and quick questionnaire, composed of 6 questions with a binary yes/no answer. It allows to assess the degree of compliance with the prescribed treatment and thus to better identify the constraints related to the treatment. The score varies from 0 to 6 depending on the presence of "yes". 0 "yes": Good compliance, more than 3 "yes": non compliance.

次要结局

  • Compliance rate with statin according to risk factors(Day 0)
  • Compliance rate with statin according to the type of prevention(Day 0)

研究者

发起方
Lille Catholic University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Statin Compliance of Patients With... | 临床试验